web analytics
3.1 C
Munich
Tuesday, April 20, 2021

TAG

GNBT

Generex Biotechnology Corporation (OTCMKTS: GNBT) Li-key Peptide; Chinese Licensing Deal

Generex Biotechnology Corporation (OTCMKTS: GNBT) is making a strong move up the charts after the Company closed a $50 million Licensing and Development Agreement...

Li-key Peptide; The Rise of Generex Biotechnology Corporation (OTCMKTS: GNBT)

Generex Biotechnology Corporation (OTCMKTS: GNBT) is an exciting biotech trading at the bottom of its range that has a promising COVID-19 Vaccine using li-key...

The Steady Rise of Generex Biotechnology Corporation (OTCMKTS:GNBT)

Generex Biotechnology Corporation (OTCMKTS: GNBT) was on the rise again as the rest of the markets dropped after the Company announced they have recieved...

Successful Dividend Review Boosts Generex Biotechnology Corporation (OTCMKTS:GNBT)

Generex Biotechnology Corporation (OTCMKTS:GNBT) has seen a significant rise in recent days after the Company reported the successful completion of the FINRA review process...

The Exciting Rise of Generex Biotechnology Corporation (OTCMKTS:GNBT)

Generex Biotechnology Corporation (OTCMKTS:GNBT) has been on the move in recent days after dipping below the $1 mark last week the stock has surged...

A Look at Generex Biotechnology Corporation (OTCMKTS:GNBT)

Generex Biotechnology Corporation (OTCMKTS:GNBT) has continued to move lower in recent months continuing a trend that has lasted for years. The stock seems to...

Latest news